|
Market Closed -
Nasdaq
00:00:00 02/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 12.89 USD | -0.77% |
|
-6.80% | +57.58% |
Company Valuation: ORIC Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 578.9 | 264.8 | 501.9 | 569.5 | 796.6 | 1,336 | - | - |
| Change | - | -54.26% | 89.55% | 13.47% | 39.89% | 67.71% | - | - |
| Enterprise Value (EV) | 578.9 | 264.8 | 266.8 | 569.5 | 751 | 1,336 | 1,336 | 1,336 |
| Change | - | -54.26% | 0.78% | 113.42% | 31.87% | 77.91% | 0% | 0% |
| P/E | -7.1x | -2.62x | -4.69x | -4.41x | -5.56x | -8.49x | -7.83x | -6.96x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0.3x | 0.4x | 0.66x | 0.3x | -2.59x | -0.93x | -0.6x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 436x |
| EV / Revenue | - | - | - | - | - | - | - | 436x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -8.28x | -8.07x | -9.34x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -7.5x | -6.55x | -5.6x |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | -9.82x | -7.91x | -6.13x |
| FCF Yield | -10.4% | -29.2% | -17.2% | -20% | -14% | -10.2% | -12.6% | -16.3% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.07 | -2.25 | -1.96 | -1.83 | -1.47 | -1.518 | -1.646 | -1.852 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 3.064 |
| EBITDA 1 | -77.97 | -90.8 | -109.7 | -141.8 | -141.8 | -161.4 | -165.6 | -143 |
| EBIT 1 | -78.87 | -91.77 | -110.8 | -142.9 | -143 | -178.2 | -203.9 | -238.7 |
| Net income 1 | -78.72 | -89.12 | -100.7 | -127.8 | -129.5 | -165.6 | -196.9 | -239.6 |
| Net Debt | - | - | -235 | - | -45.67 | - | - | - |
| Reference price 2 | 14.70 | 5.89 | 9.20 | 8.07 | 8.18 | 12.89 | 12.89 | 12.89 |
| Nbr of stocks (in thousands) | 39,382 | 44,953 | 54,552 | 70,567 | 97,389 | 103,653 | - | - |
| Announcement Date | 21/03/22 | 16/03/23 | 11/03/24 | 18/02/25 | 23/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.56x | - | - | -.--% | 1.35B | |
| 20.25x | 7.09x | 14.33x | 1.44% | 68.13B | |
| 36.11x | 9.4x | 28.68x | 0.04% | 63.6B | |
| 29.63x | 6.32x | 16.43x | -.--% | 25.57B | |
| -74.57x | 14.38x | -69.34x | -.--% | 26.6B | |
| -15.53x | 5.87x | -7.38x | -.--% | 25.52B | |
| 52.62x | 19.47x | 39.5x | 0.29% | 18.23B | |
| 26.84x | 5.04x | 16.75x | -.--% | 19.69B | |
| 1309.77x | 37.93x | 827.81x | -.--% | 15.16B | |
| 16.88x | 5.01x | 11.7x | -.--% | 13.54B | |
| Average | 139.34x | 12.28x | 97.61x | 0.18% | 27.74B | |
| Weighted average by Cap. | 85.13x | 10.41x | 54.14x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ORIC Stock
- Valuation ORIC Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
